GlassScriptPhysician profile
Jeffrey K Weiss
NPI 1316946247
$6,018.61
in general payments reported to CMS, 2019-2025
13 companies · $53.96 in 2025
The $53.96 reported for 2025 was less than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,378 · 2020: $3,397 · 2021: $893 · 2022: $114 · 2023: $30.80 · 2024: $153 · 2025: $53.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $237.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $4,560.00 | 2019-2021 | |
| Mallinckrodt Enterprises LLC | $315.63 | 2019 | |
| Celgene Corporation | $270.17 | 2019 | |
| Mallinckrodt Hospital Products INC. | $260.62 | 2020-2021 | |
| Amgen INC. | $116.21 | 2020-2025 | Krystexxa, Otezla, Enbrel |
| Pfizer INC. | $115.84 | 2019-2025 | |
| Horizon Therapeutics Plc | $109.55 | 2019-2020 | |
| Cardinal Health 110 LLC | $100.00 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $58.87 | 2024 | Orencia |
| Sanofi-Aventis U.S. LLC | $44.14 | 2019 | |
| Glaxosmithkline, LLC. | $29.24 | 2022-2023 | Benlysta |
| Ironwood Pharmaceuticals, INC | $21.74 | 2019 | |
| Ucb, INC. | $16.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Weiss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.